PND43 ECONOMIC EVALUATION OF FINGOLIMOD COMPARED TO INTERFERON-β1A IN THE TREATMENT OF PEDIATRIC-ONSET MULTIPLE SCLEROSIS (POMS) IN MEXICO
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI